During the past decade, Altru Health System Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Altru Health System Research Center" are "Atrial Fibrillation" (2 trials), "Osteoporosis" (2 trials), "Chronic Renal Insufficiency" (1 trials), "Hyperphosphatemia" (1 trials) and "Renal Failure" (1 trials). Many other conditions were trialed in "Altru Health System Research Center" in a lesser frequency.

Most popular intervention types in "Altru Health System Research Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Azimilide Dihydrochloride" (2 trials), "Placebo" (2 trials), "ALX1-11" (1 trials), "ALX1-11 (drug)" (1 trials) and "Hectorol (doxercalciferol capsules), 0.5mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Altru Health System Research Center" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Altru Health System Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Altru Health System Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Altru Health System Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".